Ockeloen, Charlotte W ; Raaijmakers, Aron ; Hijmans-van der Vegt, Manon...
Ockeloen , C W , Raaijmakers , A , Hijmans-van der Vegt , M , Bierau , J , de Vos-Geelen , J , Willemsen , A E C A B , van den Bosch , B J C & Coenen , M J H 2021 , ' Potential added value of combined DPYD/DPD genotyping and phenotyping to prevent severe toxicity in patients with a DPYD variant and decreased dihydropyrimidine dehydrogenase enzyme activity ' , Journal of Oncology Pharmacy Practice . https://doi.org/10.1177/10781552211049144.  , 2021

Ockeloen, Charlotte W ; Raaijmakers, Aron ; Hijmans-van der Vegt, Manon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749565/.  , 2021

Charlotte W Ockeloen (11733208) ; Aron Raaijmakers (11733211) ; Manon Hijmans-van der Vegt (11733214)...
https://figshare.com/articles/journal_contribution/sj-docx-1-opp-10_1177_10781552211049144_-_Supplemental_material_for_Potential_added_value_of_combined_DPYD_DPD_genotyping_and_phenotyping_to_prevent_severe_toxicity_in_patients_with_a_i_DPYD_i_variant_and_decreased_dihydropyrimidine_dehydro/17055496.  , 2021